Repo et al. developed a prognostic model combining securin, separase, and Cdk1 for predicting tumor size, histological grade, axillary lymph node status, and the risk of mortality, based on a study comprised of 1,135 BC patients 84. The gene discussed is PTTG1; the disease is neoplasm.